Alexander Villalobos

Zachary T. Berman, MD is an Associate Professor of Clinical Radiology at the University of California, San Diego, with a subspecialty focus in interventional oncology and hepatobiliary malignancies. A graduate of Case Western Reserve University School of Medicine, Dr. Berman completed his internal medicine internship and diagnostic/interventional radiology residency at UC San Diego. He now serves as a national thought leader in liver-directed therapy and interventional radiology.

Dr. Ghassan El-Haddad is the Head of the Radionuclide Therapy Program at H. Lee Moffitt Cancer Center and Research Institute. He is a Vice Chair, Radiopharmaceutical and Nuclear Oncology. Senior Member in Interventional Radiology at Moffitt Cancer Center, and a Professor of Radiology and Oncologic Sciences at the University of South Florida in Tampa, FL.
He is board certified by the American Board of Nuclear Medicine, and the American Board of Interventional Radiology/Diagnostic Radiology.
He is an active member of multiple medical societies, including the SIO, SIR, NANETS, and SNMMI. He is a member of the Therapy Center of Excellence and Targeted Radioisotope Therapy outreach working group for the SNMMI and Continuing Medical Education for NANETS. He is a principal investigator and co-investigator on several phase I/II, and phase III multicenter randomized clinical trials on Liver-directed Embolotherapy, and Radiopharmaceutical Therapy.

A member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team, Dr. Gandhi specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases.

Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude. He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center.

Dr. Gandhi also dedicated an entire year to biomedical research at Memorial Sloan-Kettering Cancer Center and also served as a research fellow at the National Institutes of Health (NIH). Prior to joining Miami Cardiac & Vascular Institute, he was an international visiting scholar at Asan Medical Center/University of Ulsan Medical School in Seoul, South Korea. He has published numerous scientific papers, authored several textbook chapters and presented his research at national and international meetings.

He is also a fellow of the Society for Vascular Medicine and a fellow of the Society of Interventional Radiology. He is the co-author of the textbook Interventional Oncology. Dr. Gandhi is also a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Venkatesh (Kavi) Krishnasamy is the Director of Interventional Oncology and Interventional Research at the University of Alabama Birmingham. His clinical focus is primarily the full gamut of Interventional Oncology and MSK/pain interventions. In particular, he specializes in complex percutaneous ablation and transarterial therapies with adjunctive techniques. His academic interests include device/software development, translational research, and multidisciplinary oncology trials. He additionally focuses on therapeutic guideline and algorithm development.